ATE395362T1 - Monoklonale antikörper zur apoptosis-induzierung - Google Patents
Monoklonale antikörper zur apoptosis-induzierungInfo
- Publication number
- ATE395362T1 ATE395362T1 AT98941848T AT98941848T ATE395362T1 AT E395362 T1 ATE395362 T1 AT E395362T1 AT 98941848 T AT98941848 T AT 98941848T AT 98941848 T AT98941848 T AT 98941848T AT E395362 T1 ATE395362 T1 AT E395362T1
- Authority
- AT
- Austria
- Prior art keywords
- antibody
- monoclonal antibodies
- associated proteins
- human integrin
- apoptosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26485397 | 1997-09-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE395362T1 true ATE395362T1 (de) | 2008-05-15 |
Family
ID=17409137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98941848T ATE395362T1 (de) | 1997-09-11 | 1998-09-11 | Monoklonale antikörper zur apoptosis-induzierung |
Country Status (14)
Country | Link |
---|---|
US (1) | US20030157100A1 (de) |
EP (1) | EP1035132B1 (de) |
KR (2) | KR20010023866A (de) |
CN (1) | CN1198845C (de) |
AT (1) | ATE395362T1 (de) |
AU (1) | AU740225B2 (de) |
CA (1) | CA2303072A1 (de) |
DE (1) | DE69839492D1 (de) |
HU (1) | HUP0003513A3 (de) |
NO (1) | NO20001238L (de) |
PL (1) | PL339265A1 (de) |
RU (1) | RU2212413C2 (de) |
SK (1) | SK3232000A3 (de) |
WO (1) | WO1999012973A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA50708C2 (uk) * | 1993-09-03 | 2002-11-15 | Чугай Сейяку Кабусікі Кайся | Моноклональне антитіло, яке має здатність розпізнавати антиген, який викликає апоптоз мієлоїдних клітин, фрагмент f(ab)2 моноклонального антитіла, гібридома ferm bp-4382 |
US7531643B2 (en) | 1997-09-11 | 2009-05-12 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibody inducing apoptosis |
US7696325B2 (en) | 1999-03-10 | 2010-04-13 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide inducing apoptosis |
EP1167388A4 (de) * | 1999-03-10 | 2002-05-29 | Chugai Pharmaceutical Co Ltd | Apoptose induzierendes einzelsträngiges fv |
TWI241345B (en) * | 2000-03-10 | 2005-10-11 | Chugai Pharmaceutical Co Ltd | Apoptosis inducing polypeptide |
US20040058393A1 (en) * | 2000-04-17 | 2004-03-25 | Naoshi Fukishima | Agonist antibodies |
AU2001246934A1 (en) * | 2000-04-17 | 2001-10-30 | Chugai Seiyaku Kabushiki Kaisha | Agonist antibodies |
KR100870123B1 (ko) | 2000-10-20 | 2008-11-25 | 츄가이 세이야꾸 가부시키가이샤 | 저분자화 아고니스트 항체 |
AU2002210917B2 (en) * | 2000-10-20 | 2006-05-18 | Chugai Seiyaku Kabushiki Kaisha | Degraded TPO agonist antibody |
DE60133479T2 (de) | 2000-10-20 | 2009-04-16 | Chugai Seiyaku K.K. | Modifizierter tpo-agonisten antikörper |
EP1327681A4 (de) | 2000-10-20 | 2004-09-01 | Chugai Pharmaceutical Co Ltd | Degradierte Agonisten Antikörper |
EP2075256A2 (de) | 2002-01-14 | 2009-07-01 | William Herman | Gezielte Liganden |
US8158385B2 (en) | 2002-10-11 | 2012-04-17 | Chugai Seiyaku Kabushiki Kaisha | Cell death-inducing agent |
JP2004279086A (ja) | 2003-03-13 | 2004-10-07 | Konica Minolta Holdings Inc | 放射線画像変換パネル及び放射線画像変換パネルの製造方法 |
EP1609803A4 (de) * | 2003-03-31 | 2006-05-24 | Chugai Pharmaceutical Co Ltd | Modifizierter antikörper gegen cd22 und anwendungen dafür |
US8613922B2 (en) | 2003-04-24 | 2013-12-24 | The University Of North Carolina At Chapel Hill | Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP) |
AU2004287722A1 (en) * | 2003-11-11 | 2005-05-19 | Chugai Seiyaku Kabushiki Kaisha | Humanized anti-CD47 antibody |
US20070281327A1 (en) * | 2003-12-12 | 2007-12-06 | Kiyotaka Nakano | Methods of Screening for Modified Antibodies With Agonistic Activities |
TW200530266A (en) * | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Method of reinforcing antibody activity |
TW200530269A (en) | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
CA2548929A1 (en) * | 2003-12-12 | 2005-06-23 | Chugai Seiyaku Kabushiki Kaisha | Cell death inducing agent |
JP5057967B2 (ja) | 2005-03-31 | 2012-10-24 | 中外製薬株式会社 | sc(Fv)2構造異性体 |
JPWO2006123724A1 (ja) * | 2005-05-18 | 2008-12-25 | 国立大学法人徳島大学 | 抗hla抗体を利用した新規医薬品 |
CN101262885B (zh) | 2005-06-10 | 2015-04-01 | 中外制药株式会社 | 含有sc(Fv)2的药物组合物 |
CA2610987C (en) | 2005-06-10 | 2013-09-10 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
WO2007033221A2 (en) * | 2005-09-13 | 2007-03-22 | The General Hospital Corporation | Methods and compositions for inhibition of immune responses |
CA2657385A1 (en) * | 2006-07-13 | 2008-01-17 | Naoki Kimura | Cell death inducer |
CL2008000719A1 (es) * | 2007-03-12 | 2008-09-05 | Univ Tokushima Chugai Seiyaku | Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a |
PT3056514T (pt) * | 2008-01-15 | 2019-07-19 | Univ Leland Stanford Junior | Métodos para manipulação de fagocitose mediada por cd47 |
ES2796085T3 (es) | 2008-01-15 | 2020-11-25 | Univ Leland Stanford Junior | Marcadores de células madre de leucemia mieloide aguda |
WO2010017332A2 (en) | 2008-08-07 | 2010-02-11 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services | Radioprotectants targeting thrombospondin-1 and cd47 |
DK2812443T3 (da) * | 2012-02-06 | 2019-08-26 | Inhibrx Inc | Cd47-antistoffer og fremgangsmåder til anvendelse deraf |
JP6572131B2 (ja) | 2012-12-12 | 2019-09-04 | バスキュロックス インコーポレイテッド | 治療用cd47抗体 |
US9221908B2 (en) | 2012-12-12 | 2015-12-29 | Vasculox, Inc. | Therapeutic CD47 antibodies |
UA126146C2 (uk) | 2015-09-18 | 2022-08-25 | Арч Онколоджі, Інк. | Терапевтичне антитіло до cd47 |
AU2017295704B2 (en) | 2016-07-13 | 2023-07-13 | President And Fellows Of Harvard College | Antigen-presenting cell-mimetic scaffolds and methods for making and using the same |
EP3529276A4 (de) | 2016-10-21 | 2020-06-17 | Arch Oncology, Inc. | Therapeutische cd47-antikörper |
MA51208A (fr) | 2017-12-01 | 2020-10-07 | Seattle Genetics Inc | Anticorps (masqués) contre cd47 et leurs utilisations pour le traîtement du cancer |
CN110066336B (zh) * | 2019-05-12 | 2021-11-09 | 杭州科兴生物科技有限公司 | 抗cd47单克隆抗体、片段及其医药用途 |
CA3234825A1 (en) | 2021-10-28 | 2023-05-04 | Lyell Immunopharma, Inc. | Methods of generating cells |
WO2024077174A1 (en) | 2022-10-05 | 2024-04-11 | Lyell Immunopharma, Inc. | Methods for culturing nr4a-deficient cells |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE199392T1 (de) * | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
UA50708C2 (uk) * | 1993-09-03 | 2002-11-15 | Чугай Сейяку Кабусікі Кайся | Моноклональне антитіло, яке має здатність розпізнавати антиген, який викликає апоптоз мієлоїдних клітин, фрагмент f(ab)2 моноклонального антитіла, гібридома ferm bp-4382 |
US6719972B1 (en) * | 1994-06-03 | 2004-04-13 | Repligen Corporation | Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies |
US5885574A (en) * | 1994-07-26 | 1999-03-23 | Amgen Inc. | Antibodies which activate an erythropoietin receptor |
EP0903149A4 (de) * | 1996-03-06 | 2002-02-13 | Chugai Pharmaceutical Co Ltd | Verfahren zur bewertung von apoptosisverursachende substanzen |
US7531643B2 (en) * | 1997-09-11 | 2009-05-12 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibody inducing apoptosis |
US7696325B2 (en) * | 1999-03-10 | 2010-04-13 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide inducing apoptosis |
-
1998
- 1998-09-11 KR KR1020007002548A patent/KR20010023866A/ko not_active Application Discontinuation
- 1998-09-11 AT AT98941848T patent/ATE395362T1/de not_active IP Right Cessation
- 1998-09-11 PL PL98339265A patent/PL339265A1/xx unknown
- 1998-09-11 DE DE69839492T patent/DE69839492D1/de not_active Expired - Lifetime
- 1998-09-11 HU HU0003513A patent/HUP0003513A3/hu unknown
- 1998-09-11 CA CA002303072A patent/CA2303072A1/en not_active Abandoned
- 1998-09-11 AU AU90028/98A patent/AU740225B2/en not_active Ceased
- 1998-09-11 KR KR10-2004-7019086A patent/KR20040106585A/ko active IP Right Grant
- 1998-09-11 RU RU2000109293/13A patent/RU2212413C2/ru not_active IP Right Cessation
- 1998-09-11 WO PCT/JP1998/004118 patent/WO1999012973A1/ja active IP Right Grant
- 1998-09-11 EP EP98941848A patent/EP1035132B1/de not_active Expired - Lifetime
- 1998-09-11 CN CNB988103435A patent/CN1198845C/zh not_active Expired - Fee Related
-
2000
- 2000-03-07 SK SK323-2000A patent/SK3232000A3/sk unknown
- 2000-03-09 NO NO20001238A patent/NO20001238L/no unknown
-
2003
- 2003-03-10 US US10/383,512 patent/US20030157100A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL339265A1 (en) | 2000-12-04 |
DE69839492D1 (de) | 2008-06-26 |
CN1276798A (zh) | 2000-12-13 |
HUP0003513A3 (en) | 2004-05-28 |
US20030157100A1 (en) | 2003-08-21 |
CN1198845C (zh) | 2005-04-27 |
WO1999012973A1 (fr) | 1999-03-18 |
EP1035132A4 (de) | 2005-02-09 |
KR20040106585A (ko) | 2004-12-17 |
HUP0003513A2 (hu) | 2001-02-28 |
EP1035132B1 (de) | 2008-05-14 |
AU9002898A (en) | 1999-03-29 |
AU740225B2 (en) | 2001-11-01 |
SK3232000A3 (en) | 2000-09-12 |
NO20001238L (no) | 2000-05-11 |
EP1035132A1 (de) | 2000-09-13 |
CA2303072A1 (en) | 1999-03-18 |
KR20010023866A (ko) | 2001-03-26 |
NO20001238D0 (no) | 2000-03-09 |
RU2212413C2 (ru) | 2003-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69839492D1 (de) | Monoklonale antikörper zur apoptosis-induzierung | |
DE60226641D1 (de) | Antikörperkategorisierung auf der grundlage von bindungseigenschaften | |
DE69635377D1 (de) | Effiziente anreicherung und detektion von ausgesäten tumorzellen | |
DE69813158T2 (de) | Assays zur Bestimmung von Proteinfragmenten in biologischen Medien | |
ZA946767B (en) | Monocional antibodies having property of causing apoptosis. | |
ATE123652T1 (de) | Antigene. | |
DK1565489T3 (da) | Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet | |
CU22615A1 (es) | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos | |
DK0742795T3 (da) | Immunstimulerende monoklonale antistoffer | |
ATE202116T1 (de) | Antikörperklassenspezifisches entstörungsreagenz | |
DE69622259T2 (de) | Cd40 bindendes protein zur stimulierung der immunantwort | |
DE69504959D1 (de) | Humanisierte monoklonale antikörper gegen humanes interleukin - 4 | |
ATE206621T1 (de) | Il-8 antagonisten zur behandlung von asthma | |
DE59505585D1 (de) | Antigene und Antikörper zum Nachweis von Kollagen I | |
ATE266203T1 (de) | Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum | |
CY1106349T1 (el) | Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c | |
DE69728897D1 (de) | Saeugetierchemokine | |
ES2061324T3 (es) | Complejo aglutinante como reactivo de identificacion de grupo sanguineo. | |
DE69132144D1 (de) | Menschliche phospholipase aktivierender proteinteil | |
DE69533904D1 (de) | Chemische Modifikation von Antikörpern und Antigenen | |
DE69026812D1 (de) | Konjugate von "pokeweed" antiviralem protein und monoklonalen antikörpern | |
GR890100219A (el) | Ανθρωπινα μονοκλωνικα αντισωματα που ειδικα αναγνωριζουν κυτταραιου λυσσας κυτταρα που παραγουν τα ιδια, διαμορφωσεις που περιε χουν τα ιδια και παραγωγη ολων αυτων. | |
ATE227027T1 (de) | Zytofluorometrisches verfahren zur bestimmung von antikörper gegen tumorantigene im serum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |